Company intelligence / Profile preview

Anika Therapeutics

Bedford, Massachusetts, USAanika.com ↗
Ownership
Public · ANIK
Employees
~350
Development stage
Commercial
01

Overview

Anika has multiple commercialized products for osteoarthritis pain management and regenerative orthopedic solutions. Its lead pipeline product "Hyalofast" completed pivotal Phase III enrollment in the US as of late 2023. The company’s Integrity™ Implant System for tendon repair received FDA clearance and launched commercially in the US in early/mid–2024. Tactoset®, an HA-enhanced bone substitute, has expanded FDA clearances including use with autologous bone marrow aspirate.

Therapeutic areas
OtherRheumatology
Modalities
BiologicDeviceHydrogel-based drug delivery therapyRecombinant protein (hyaluronic acid-based)
Industry
Biotech
02

Drug pipeline

12 assets

esterified hyaluronic acid matrix

Preclinical

11 more assets in the full pipeline.

Request access →
03

Partnerships

Johnson & Johnson (distribution)Boehringer Ingelheim Vetmedica (veterinary distribution)MedtronicMedline
04

Financials

Market cap
$279.4M
Total revenue
$32.6M
Enterprise value
$264.3M

Beyond the preview

Go deeper on Anika Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anika Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call